New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
10:23 EDTSDT, GDOT, INSY, EXPE, DEPO, CPN, EZPW, BYIHigh option volume stocks
High option volume stocks: TTTN BYI EZPW CPN XEO DEPO EXPE INSY GDOT SDT
News For BYI;EZPW;CPN;DEPO;EXPE;INSY;GDOT;SDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
17:08 EDTINSYInsys Therapeutics receives purported service of notice of three IPR petitions
On August 26, Insys Therapeutics received purported service of notice of three inter partes review petitions filed by a hedge fund with the U.S. Patent and Trademark Office, challenging three of the four Orange Book-listed patents covering Subsys. The company intends to oppose the request to institute the IPR and, if any of the three petitions are granted, the company intends to defend the validity of each patent challenged in each IPR.
August 25, 2015
11:23 EDTEXPEAnalyst says Priceline undervalued, looks poised to outperform
Subscribe for More Information
09:19 EDTGDOTGreen Dot upgraded to Outperform from Sector Perform at Portales
Portales upgraded Green Dot to Outperform due to valuation and said the recent buyback and Wal-Mart contract renewal announcements led the firm to raise 2016 estimates.
August 21, 2015
17:29 EDTCPNPJM releases results for 2018-2019 PJM Interconnection capacity auction
Subscribe for More Information
16:07 EDTCPNLuminus Management raises stake in Calpine to 7.6% from 6.6%
Subscribe for More Information
13:04 EDTDEPODepomed to file revocation statement with SEC
Subscribe for More Information
August 19, 2015
17:40 EDTDEPODepomed sends letter to Horizon Pharma CEO
Subscribe for More Information
17:38 EDTDEPODepomed board unanimously rejects revised proposal from Horizon Pharma
Subscribe for More Information
17:36 EDTDEPODepomed board unanimously rejects revised proposal from Horizon Pharma
Subscribe for More Information
August 18, 2015
16:10 EDTEZPWEZCORP receives Nasdaq deficiency notice
Subscribe for More Information
08:16 EDTINSYInsys Therapeutics files citizen petition with DEA to reschedule synthetic CBD
Insys Therapeutics announced it has filed a Citizen Petition with the DEA to request the agency reschedule its synthetic pharmaceutical cannabidiol, or CBD, from Schedule I to Schedule IV. The company believes that the current classification of synthetic CBD as a Schedule I compound is a significant barrier to the progress of research studies that explore the value of this compound in the treatment of several serious medical conditions.
August 17, 2015
12:24 EDTINSYInsys dronabinol oral solution NDA accepted for filing by FDA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use